This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_SMALL_INTESTINE_NEUROENDOCRINE_EXALLC for full statistics.
Neuroendocrine tumor and carcinoma of small intestine
C3_SMALL_INTESTINE_NEUROENDOCRINE
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
450 |
4. Check minimum number of eventsNone |
450 |
5. Include endpointsNone |
450 |
6. Filter based on genotype QC (FinnGen only) |
450 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF8
Similar endpoints
↥List of similar endpoints to
Neuroendocrine tumor and carcinoma of small intestine
based on the number of shared cases.
Similar with more cases:
- Neuroendocrine tumor and carcinoma of small intestine, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of small intestine
- Malignant neoplasm of small intestine, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of digestive organs
- Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 450 | 217 | 233 |
| Unadjusted period prevalence (%) | 0.09 | 0.07 | 0.10 |
| Median age at first event (years) | 63.05 | 61.11 | 64.85 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 419
- Matched controls
- 4188
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C17.9
ICD-10 Finland
Malignant neoplasm: Small intestine, unspecified
2056.9
295.5
252
*
JFB00
NOMESCO Finland
Partial resection of small intestine
132.5
189.6
194
27
130
Kela drug reimbursment
Malignant tumour
26.5
162.0
248
217
8240/3-C17.9
ICD-O-3
Neuroendocrine tumor, NOS, of small intestine, NOS
+∞
153.9
138
*
D37.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Small intestine
422.9
148.9
141
5
H01CB03
ATC
lanreotide; parenteral
953.1
142.8
132
*
C17.2
ICD-10 Finland
Malignant neoplasm: Ileum
630.6
141.2
132
*
E34.0
ICD-10 Finland
Carcinoid syndrome
1711.0
132.8
122
*
H01CB02
ATC
octreotide; parenteral
851.0
131.0
122
*
8240/3-C17.2
ICD-O-3
Neuroendocrine tumor, NOS, of ileum
+∞
117.3
107
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
14.2
69.6
126
123
XX7JT
NOMESCO Finland
Somatostatin isotope ablative therapy
763.8
68.0
65
*
JN7AQ
NOMESCO Finland
Somatostatin receptor SPET med low dose CT
264.8
67.3
67
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
26.0
66.5
94
46
JN5ER
NOMESCO Finland
PET-CT of receptors in whole body
127.8
61.8
65
6
JN3BD
NOMESCO Finland
Extensive abdominal CT
7.9
61.0
161
305
JN4BD
NOMESCO Finland
Extensive body CT
7.7
60.3
163
319
8249/3-C17.9
ICD-O-3
Neuroendocrine tumor, grade 2 of small intestine, NOS
+∞
52.2
49
*
D77
ICPC
Malignant digestive neopl other/NOS
103.0
50.2
54
6
8249/3-C17.2
ICD-O-3
Neuroendocrine tumor, grade 2 of ileum
+∞
50.0
47
*
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
50.5
47.7
57
13
XX9AN
NOMESCO Finland
Complementary isotope examination or additional picture
180.1
46.9
48
*
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
13.2
46.6
85
79
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
14.5
46.5
81
68
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
37.0
43.2
55
17
C17.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of small intestine
232.6
41.7
42
*
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
13.6
40.9
73
64
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
4.1
40.3
234
983
B01AB05
ATC
enoxaparin; parenteral
4.0
39.0
227
948
JN4CD
NOMESCO Finland
Very extensive body CT
10.6
38.9
79
90
JN4AD
NOMESCO Finland
Body CT examination
6.5
36.0
102
196
JFB30
NOMESCO Finland
Right hemicolectomy
18.3
35.8
56
35
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
6.6
34.0
95
178
302
Kela drug reimbursment
Interferon alfa
+∞
32.7
31
*
UJF32
NOMESCO Finland
Coloscopy
3.6
31.2
190
780
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
3.5
30.5
199
859
T73
ICPC
Neoplasm endocrine other/unspecified
+∞
29.5
28
*
JAH00
NOMESCO Finland
Laparotomy
13.3
29.4
52
44
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
15.8
29.2
48
34
C10AC01
ATC
colestyramine; oral
12.2
28.7
53
49
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
11.5
28.4
54
53
WX408
NOMESCO Finland
General anesthesy, balanced
3.4
28.3
182
764
JFB20
NOMESCO Finland
Ileocaecal resection
83.6
28.2
31
*
C17.1
ICD-10 Finland
Malignant neoplasm: Jejunum
300.4
28.1
28
*
JFB31
NOMESCO Finland
Laparoscopic right hemicolectomy
20.5
27.6
41
22
JKA20
NOMESCO Finland
Cholecystectomy
10.5
26.6
53
57
TPH07
NOMESCO Finland
Cathetrisation of artery
4.7
26.6
101
266
D13.3
ICD-10 Finland
Benign neoplasm: Other and unspecified parts of small intestine
37.0
24.6
31
9
L03AB05
ATC
interferon alfa-2b; parenteral
59.8
24.3
28
5
8246/3-C17.9
ICD-O-3
Neuroendocrine carcinoma, NOS, of small intestine, NOS
+∞
23.1
22
*
C17.0
ICD-10 Finland
Malignant neoplasm: Duodenum
242.6
22.8
23
*
JN7AN
NOMESCO Finland
Somatostatin receptor isotope imaging
+∞
22.1
21
*
JN7SN
NOMESCO Finland
Somatostatin receptor SPECT
+∞
22.1
21
*
JN3AD
NOMESCO Finland
Abdominal CT examination
4.9
21.7
76
181
8240/3-C17.0
ICD-O-3
Neuroendocrine tumor, NOS, of duodenum
+∞
21.0
20
*
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
18.1
20.8
32
19
UJF30
NOMESCO Finland
Ileoscopy through colon
4.2
20.1
82
227
A09AA02
ATC
multienzymes (lipase, protease etc.)
11.8
20.1
37
34
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
14.4
18.5
31
23
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
5.5
18.1
55
111
JAH01
NOMESCO Finland
Laparoscopy
7.8
18.1
42
59
L01AX03
ATC
temozolomide; systemic
21.2
18.0
26
13
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
13.4
17.4
30
24
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
8.4
17.2
38
49
JF1BD
NOMESCO Finland
Very extensive small bowel CT
52.3
17.1
20
*
A03FA01
ATC
metoclopramide; systemic, rectal
2.8
16.9
130
573
UJF92
NOMESCO Finland
Capsular endoscopy
10.7
16.7
32
32
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
6.3
16.4
44
76
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.3
15.9
89
318
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.4
15.7
178
973
8246/3-C17.2
ICD-O-3
Neuroendocrine carcinoma, NOS, of ileum
+∞
15.7
15
*
TPH04
NOMESCO Finland
Cathetrisation of vein
2.7
15.7
131
607
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
39.7
15.5
19
5
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
5.4
15.5
47
95
ZXE10
NOMESCO Finland
More than one and less than three hours
2.4
15.4
192
1100
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
29.9
15.3
20
7
A79
ICPC
Malignancy NOS
11.0
14.9
28
27
B01AB10
ATC
tinzaparin; parenteral
3.9
14.3
61
174
K56.7
ICD-10 Finland
Ileus, unspecified
11.5
14.2
26
24
133
Kela drug reimbursment
Severe chronic pancreatic insufficiency
11.5
13.7
25
23
R4190
NOMESCO Finland
Nutritional therapy
6.5
13.5
35
58
XX9AD
NOMESCO Finland
Complementary CT
+∞
12.6
12
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.0
12.0
49
135
JN3DG
NOMESCO Finland
Very extensive MRI examination with high intensity magnet
48.1
11.9
14
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.4
11.9
59
191
SPAT1256
SPAT
Intramuscular and subcutaneous injection
2.1
11.7
209
1356
ZXE20
NOMESCO Finland
More than three and less than five hours
2.6
11.4
90
394
Z51.88
ICD-10 Finland
Other specified medical care
8.0
11.3
25
33
JN4DD
NOMESCO Finland
Scout CT scan of torso
28.9
10.8
14
5
JFA73
NOMESCO Finland
Excision of lesion of small intestine
112.7
10.5
11
*
Z51.5
ICD-10 Finland
Palliative care
3.4
10.3
50
159
E34.9
ICD-10 Finland
Endocrine disorder, unspecified
24.1
10.3
14
6
ZX114
NOMESCO Finland
Intramuscular
11.7
10.1
18
16
A02BC02
ATC
pantoprazole; systemic
2.0
10.0
293
2245
WX402
NOMESCO Finland
General anaesthesia
2.5
10.0
87
398
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
9.4
9.6
19
21
N02AA05
ATC
oxycodone; systemic
2.4
9.5
91
440
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.9
9.1
213
1482
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
3.1
8.9
49
169
ZXD05
NOMESCO Finland
Urgent procedure
2.0
8.7
145
887
JFB21
NOMESCO Finland
Laparoscopic ileocaecal resection
51.1
8.7
10
*
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.4
8.6
77
358
K56.0
ICD-10 Finland
Paralytic ileus
11.9
8.6
15
13
C78.8
ICD-10 Finland
Secondary malignant neoplasm of other and unspecified digestive organs
28.1
8.5
11
*
R10.0
ICD-10 Finland
Acute abdomen
5.2
8.5
25
50
JN5SR
NOMESCO Finland
Very extensive PET-CT of receptors in upper body
+∞
8.4
8
*
8240/3-C17.1
ICD-O-3
Neuroendocrine tumor, NOS, of jejunum
+∞
8.4
8
*
1522B
ICD-9 Finland
Malignant neoplasm of small intestine, including duodenum, Ileum[NEOPLASMA MALIGNUM ILEI,ALIA DEFINITA SEU NUD]
+∞
8.4
8
*
N02BE01
ATC
paracetamol; systemic, rectal
2.4
8.2
372
3229
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.2
8.1
93
487
D37.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified
17.6
8.1
12
7
JFB33
NOMESCO Finland
Other resection comprising small intestine and colon
34.0
8.1
10
*
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
3.5
7.9
36
110
ZXK00
NOMESCO Finland
Conversion from percutaneous endoscopic to open procedure
15.4
7.8
12
8
I36.1
ICD-10 Finland
Nonrheumatic tricuspid (valve) insufficiency
8.3
7.7
16
20
D75
ICPC
Malignant neoplasm colon/rectum
12.1
7.6
13
11
D64.9
ICD-10 Finland
Anaemia, unspecified
2.5
7.5
58
250
C17
ICD-10 Finland
Malignant neoplasm of small intestine
81.4
7.4
8
*
K50.9
ICD-10 Finland
Crohn disease, unspecified
11.1
7.3
13
12
C17.3
ICD-10 Finland
Malignant neoplasm: Meckel diverticulum
+∞
7.3
7
*
E340, C179
ICD-10 Finland
NA
+∞
7.3
7
*
C18.09
ICD-10 Finland
Malignant tumor of caecum other or unspecified histology
16.1
7.3
11
7
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.1
7.2
94
517
6402
FHL
Small bowel resection
30.6
7.2
9
*
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
3.7
7.2
30
86
L01BC06
ATC
capecitabine; oral
3.7
7.2
30
86
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.2
7.1
78
397
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
7.7
7.0
15
20
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
2.5
6.8
51
217
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
3.4
6.8
31
96
C26.0
ICD-10 Finland
Malignant neoplasm: Intestinal tract, part unspecified
22.9
6.7
9
*
D99
ICPC
Disease digestive system other
12.5
6.6
11
9
C26.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of digestive system
70.9
6.4
7
*
C18.99
ICD-10 Finland
Malignant tumor in unspecified location in the colon other or unspecified histology
14.6
6.4
10
7
ZXE60
NOMESCO Finland
More than 12 and less than 15 hours
14.6
6.4
10
7
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.3
6.4
61
294
B03BA03
ATC
hydroxocobalamin; parenteral
3.0
6.4
36
128
A04AA02
ATC
granisetron; systemic, transdermal
3.0
6.3
36
129
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
7.2
6.3
14
20
JJA20
NOMESCO Finland
Open biopsy of liver
27.1
6.2
8
*
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
3.1
6.2
32
109
ZX112
NOMESCO Finland
Subcutaneous
4.7
6.0
19
42
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
344
17
855.80
307.65
9.3
2.2
nmol/l
344.7
69.5
8.38
344
17
(4035726)
189
347
8.67
108.84
1.6
1.4
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
173
461
5.47
64.04
3.2
4.3
ug/l
3.4
37.3
1.24
135
390
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
134
367
4.78
46.40
2.6
2.2
g/l
0.2
0.2
1.59
126
343
(3000570) Elastase.pancreatic [Mass/mass] in Stool
68
119
6.55
38.46
1.4
1.5
ug/g
208.2
277.0
2.27
56
72
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
333
1953
3.71
34.39
8.4
6.9
mmol/l
1.2
1.2
2.01
277
1663
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
307
1796
3.23
30.05
7.0
6.0
mmol/l
1.2
1.2
0.89
295
1625
(3013650) Neutrophils [#/volume] in Blood by Automated count
342
2147
3.47
29.35
15.8
9.4
e9/l
3.7
4.2
4.68
319
1878
(3018418) pH of Serum or Plasma
232
1180
2.99
28.85
5.8
4.1
ph
7.4
7.4
0.46
54
213
(40758558) Short blood count panel - Blood
201
959
2.98
27.87
11.8
7.0
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
408
2944
5.13
26.78
19.3
7.9
u/l
88.7
80.0
1.76
402
2751
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
72
182
4.52
26.69
2.1
3.4
u/ml
18.6
7096.6
0.69
66
153
(3044640) Blood type and Crossmatch panel - Blood
234
1238
2.85
26.38
3.0
2.3
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
135
545
3.11
24.78
2.9
2.4
%
21.0
22.0
0.28
116
464
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
29
6
51.46
24.58
2.0
2.3
pmol/l
50.7
102.5
—
23
6
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
237
1302
2.73
24.23
4.3
3.1
ng/l
1351.1
1350.1
0.00
212
1113
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
292
1790
2.80
23.87
4.6
4.0
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
118
459
3.13
22.91
2.8
2.8
umol/l
9.8
10.0
0.03
106
410
(42870588) Differential panel, method unspecified - Blood
226
1238
2.66
22.87
9.4
5.6
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
142
618
2.90
22.51
3.0
2.4
umol/l
12.2
12.7
0.28
136
570
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
97
339
3.37
22.47
3.4
3.1
ng/l
113.8
209.3
3.32
88
308
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
220
1213
2.59
21.64
4.0
3.4
u/l
33.9
33.7
0.02
214
1154
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
183
935
2.61
20.93
2.6
2.3
—
—
—
0
0
(40768441) Liver Pathology biopsy report
25
28
9.39
20.49
1.1
1.2
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
336
2311
2.79
20.28
6.3
4.8
mmol/l
6.7
6.8
0.25
331
2177
(3015377) Calcium [Moles/volume] in Serum or Plasma
230
1328
2.50
20.07
7.4
3.5
mmol/l
2.3
2.4
0.42
213
1151
(3032080) INR in Blood by Coagulation assay
270
1681
2.52
19.94
8.7
9.2
inr
1.3
1.3
0.14
87
447
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
216
1248
2.41
18.36
3.0
2.5
u/l
60.0
56.9
0.36
207
1158
(3006504) Eosinophils/100 leukocytes in Blood
268
1723
2.37
17.56
10.0
5.7
%
3.2
2.9
1.55
258
1602
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
79
281
3.20
17.53
1.8
1.7
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
261
1680
2.32
16.76
10.1
5.7
%
0.7
0.7
1.02
252
1567
(3001604) Monocytes [#/volume] in Blood
278
1838
2.34
16.75
10.0
5.6
e9/l
0.6
0.6
0.78
249
1576
(3019069) Monocytes/100 leukocytes in Blood
266
1734
2.31
16.47
10.3
6.0
%
9.6
8.8
3.82
257
1621
(3019198) Lymphocytes [#/volume] in Blood
281
1875
2.33
16.45
10.0
5.7
e9/l
1.6
1.9
4.36
250
1653
(3006315) Basophils [#/volume] in Blood
278
1847
2.32
16.43
10.0
5.6
e9/l
0.0
0.0
1.29
247
1596
(3002030) Lymphocytes/100 leukocytes in Blood
269
1766
2.30
16.31
10.2
5.9
%
26.5
27.0
0.31
260
1641
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
175
963
2.34
16.16
2.7
2.1
mg/l
3.2
3.2
0.14
157
833
(3013115) Eosinophils [#/volume] in Blood
281
1906
2.26
15.37
10.1
5.9
e9/l
0.2
0.2
0.10
251
1674
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
88
358
2.81
15.29
2.9
2.4
u/l
33.4
31.9
0.15
77
301
(3018010) Neutrophils/100 leukocytes in Blood
262
1740
2.21
14.94
10.2
5.6
%
57.8
57.6
0.10
252
1630
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
323
2358
2.31
14.26
5.5
3.2
u/l
65.6
54.0
1.49
315
2182
(3012095) Magnesium [Moles/volume] in Serum or Plasma
126
634
2.37
13.99
5.5
3.2
mmol/l
0.8
0.8
1.41
120
596
(40768804) Tissue Pathology biopsy report
232
1507
2.11
13.54
2.7
2.2
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
246
1646
2.09
13.12
18.1
9.7
e9/l
0.0
0.0
0.54
216
1347
(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine
12
0
+∞
12.56
1.8
0.0
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
176
1058
2.09
12.34
3.6
3.1
—
—
—
0
0
(3026782) Osmolality of Urine
139
782
2.12
11.46
3.3
2.9
mosm/kgh2o
582.5
555.4
0.73
118
670
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
137
772
2.11
11.22
5.7
3.1
mmol/l
2.5
2.5
0.07
129
677
(3030467) Casts [#/volume] in Urine by Automated count
178
1105
2.01
11.18
3.6
3.2
e6/l
0.6
0.6
0.07
141
835
(3001122) Ferritin [Mass/volume] in Serum or Plasma
224
1511
1.96
11.03
3.5
2.6
ug/l
158.2
150.1
0.18
211
1383
(3002582) Erythrocytes [#/volume] in Urine
190
1213
1.98
10.97
3.8
3.3
e6/l
48.9
110.7
0.57
152
948
(3023368) Bacteria identified in Blood by Culture
180
1128
1.99
10.96
5.7
4.3
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
142
831
2.04
10.38
2.7
2.6
e6/l
5.2
4.6
0.30
119
735
(3002256) Pathology report gross observation
95
477
2.26
10.31
1.5
1.3
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
90
458
2.21
9.39
3.5
4.6
u/l
227.3
264.6
1.14
83
434
(3018095) Leukocytes [#/volume] in Urine
203
1379
1.86
9.31
4.4
3.8
e6/l
395.3
97.0
0.61
157
1012
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
115
648
2.04
9.19
3.3
2.9
e6/l
2.9
2.0
0.38
64
368
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
209
1440
1.84
9.10
3.7
3.3
—
—
—
0
0
(3022145) Colonoscopy Study observation
87
443
2.19
9.05
1.4
1.3
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
228
1620
1.83
8.93
2.3
2.0
pmol/l
85.4
95.7
2.91
151
828
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
68
320
2.33
8.51
4.8
4.0
mmol/l
1.2
1.2
0.38
68
277
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
19
42
4.68
8.19
1.2
1.2
nmol/l
0.6
0.5
0.70
19
37
(40768797) Stomach Pathology biopsy report
97
538
2.02
8.00
1.6
1.2
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
29
92
3.30
7.68
1.2
1.3
—
—
—
0
0
(3000991) Gas panel - Venous blood
67
328
2.23
7.62
6.6
8.3
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
412
3647
2.54
7.35
27.9
15.7
mg/l
28.5
24.8
1.62
383
2923
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
114
688
1.88
7.29
3.2
2.8
e6/l
1.1
1.1
0.04
63
401
(3027801) Oxygen [Partial pressure] in Arterial blood
88
491
1.98
7.09
4.1
7.3
kpa
12.6
12.1
0.39
82
473
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
88
491
1.98
7.09
4.1
7.3
kpa
5.1
5.1
0.18
83
473
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
17
39
4.49
7.02
1.1
1.2
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
28
92
3.18
7.02
1.1
1.1
titre
—
91.7
—
0
6
(3044889) 12 lead EKG panel
331
2728
1.81
7.01
4.9
4.2
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
44
187
2.50
6.87
1.3
2.0
g/l
1.5
1.5
0.10
35
167
(3002173) Hemoglobin [Mass/volume] in Arterial blood
76
407
2.04
6.85
4.2
7.9
g/l
119.7
121.4
0.28
71
397
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
48
214
2.39
6.77
5.0
9.5
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
206
1507
1.68
6.64
3.1
2.2
nmol/l
67.5
77.6
5.60
193
1317
(3021960) Folate [Moles/volume] in Serum or Plasma
147
988
1.72
6.46
1.8
1.6
nmol/l
21.6
21.1
0.15
137
821
(3003396) Base excess in Arterial blood by calculation
86
492
1.92
6.41
4.2
7.3
mmol/l
0.2
1.2
1.52
67
393
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
16
39
4.22
6.14
1.2
1.2
nmol/l
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
32
125
2.68
5.93
3.8
3.6
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
325
2732
1.68
5.67
4.7
3.8
pmol/l
14.3
14.9
4.62
303
2432
(3019309) Folate [Moles/volume] in Red Blood Cells
116
755
1.72
5.62
1.7
1.8
nmol/l
1272.2
1210.0
0.22
93
574
(3026008) Bacteria identified in Urine by Culture
167
1196
1.63
5.61
3.7
3.3
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
16
42
3.91
5.58
1.3
1.4
e6/l
16002.0
32982.8
—
5
27
(3037467) Urinalysis macro (dipstick) panel - Urine
307
2559
1.63
5.38
4.4
4.4
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
82
490
1.82
5.30
2.5
2.5
%
1.7
1.8
0.20
75
451
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
32
133
2.51
5.26
2.9
2.3
u/ml
0.3
0.4
1.10
14
73
(3048689) Calprotectin [Mass/mass] in Stool
68
385
1.90
5.19
2.1
2.2
ug/g
223.6
138.0
0.55
59
305
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
55
303
1.93
4.56
4.5
3.7
ng/l
119.4
83.4
1.60
50
265
(3045788) Cell count panel - Pleural fluid
14
39
3.67
4.52
1.2
1.4
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
15
45
3.41
4.36
1.3
1.4
e6/l
15858.4
1150.4
—
7
33
(3025941) Bacteria identified in Stool by Culture
39
197
2.07
4.12
1.4
1.3
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
200
1579
1.48
4.00
3.7
3.9
ng/l
59.2
35.2
0.49
142
1206
(3012501) Base excess in Blood by calculation
20
78
2.64
3.77
5.4
4.4
mmol/l
4.8
2.2
2.05
15
51
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
9
16
5.72
3.67
3.2
1.5
umol/l
23.8
29.3
—
9
16
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
386
3523
1.67
3.59
30.7
14.4
ml/min/173m2
76.0
76.9
0.38
369
2922
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
24
105
2.36
3.59
2.4
1.6
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
8
13
6.24
3.51
1.0
1.2
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
410
3814
1.84
3.44
27.2
14.7
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
87
596
1.57
3.33
2.2
2.0
—
—
—
0
0
(1616796) Gas panel - Central venous blood
19
78
2.50
3.26
2.7
3.8
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
9
19
4.81
3.25
5.7
4.8
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
12
38
3.22
3.23
1.6
1.4
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
7
12
5.90
3.03
1.0
1.1
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
7
12
5.90
3.03
1.0
1.1
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
13
46
2.88
2.94
3.2
3.1
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
26
129
2.08
2.92
1.2
1.2
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
123
930
1.44
2.91
1.4
1.3
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
49
301
1.70
2.89
4.5
4.1
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
7
13
5.45
2.88
1.6
1.7
ug/l
48.7
65.0
—
7
13
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
113
848
1.44
2.78
2.0
1.8
pmol/l
98990298.1
427.3
0.50
99
696
(3012544) pH of Venous blood
59
387
1.60
2.71
5.5
3.6
—
—
—
0
0
(3035880) pH of Pleural fluid
9
24
3.80
2.68
1.2
1.2
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
68
463
1.55
2.67
1.6
1.8
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
57
373
1.60
2.65
5.6
3.5
mmol/l
1.2
2.0
0.59
46
301
(3022217) INR in Platelet poor plasma by Coagulation assay
80
567
1.50
2.62
26.5
24.7
inr
1.2
1.3
—
8
68
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
7
15
4.72
2.60
1.0
3.3
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
354
3238
1.44
2.55
32.6
16.9
%
37.6
39.5
3.87
274
2189
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
61
413
1.55
2.46
4.5
3.5
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
76
1032
0.68
2.39
1.7
1.6
mmol/l
1.4
1.4
0.24
61
840
(3012441) Differential panel - Pleural fluid
12
46
2.65
2.37
1.3
1.5
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
7
17
4.17
2.37
1.0
2.3
%
98.7
104.4
—
7
17
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
67
469
1.50
2.33
1.6
1.9
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
55
369
1.56
2.32
2.5
2.6
e9/l
66.0
70.7
0.46
40
295
(21494814) CD8 cells/100 lymphocytes in Specimen
5
9
5.60
2.22
3.2
1.4
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
11
42
2.66
2.20
3.6
3.2
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
19
95
2.04
2.14
2.8
2.8
umol/l
28.6
33.3
0.55
14
78
(3021601) Nitrite [Presence] in Urine by Test strip
213
1832
1.31
2.12
5.4
5.2
estimate
0.0
0.0
0.00
61
338
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
341
3647
0.73
2.07
4.2
4.7
mmol/l
1.4
1.5
0.92
309
3323
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
87
657
1.40
2.04
2.2
1.9
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
9
32
2.85
2.01
2.9
2.9
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
354
3760
0.73
2.00
4.5
5.3
mmol/l
2.5
2.7
2.69
319
3425
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
38
243
1.62
1.97
1.7
1.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
98
1234
0.74
1.93
2.9
3.2
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
12
52
2.34
1.89
1.2
1.8
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
330
3534
0.75
1.88
3.9
4.3
mmol/l
1.4
1.3
1.29
296
3205
(3025130) Human papilloma virus identified in Specimen
8
28
2.89
1.87
2.3
1.9
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
345
3670
0.74
1.86
4.2
4.8
mmol/l
4.4
4.6
3.13
312
3373
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
10
40
2.53
1.84
1.3
1.7
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
5
12
4.20
1.83
6.6
2.1
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
213
1858
1.28
1.82
3.9
3.9
estimate
0.0
0.0
0.00
60
324
(3014765) Yersinia sp identified in Stool by Organism specific culture
21
116
1.85
1.81
1.1
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
21
116
1.85
1.81
1.1
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
21
116
1.85
1.81
1.1
1.2
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
210
1833
1.27
1.77
3.9
3.9
estimate
0.0
0.0
0.00
61
338
(3020891) Body temperature
28
171
1.68
1.75
4.5
3.9
—
—
—
0
0
(4281824)
9
36
2.53
1.75
1.1
1.1
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
41
278
1.52
1.69
4.8
6.5
mmol/l
24.0
24.6
0.49
35
262
(3013139) Helicobacter pylori Ag [Presence] in Stool
34
221
1.58
1.68
1.1
1.2
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
13
62
2.13
1.67
2.2
3.0
e9/l
4.3
4.5
0.17
13
62
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
7
25
2.83
1.65
1.0
1.0
—
—
—
0
0
(3019060) Gas panel - Arterial blood
43
297
1.50
1.63
3.2
4.3
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
8
171
0.46
1.62
1.8
1.4
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
18
99
1.85
1.59
1.3
1.6
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
33
218
1.55
1.54
2.7
2.5
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
0
42
0.00
1.53
0.0
1.2
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
5
15
3.36
1.52
3.2
1.5
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
60
449
1.39
1.50
1.9
1.6
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
13
65
2.03
1.50
2.4
3.5
%
56.8
59.4
0.40
13
65
(40768443) Skin Pathology biopsy report
27
171
1.62
1.50
1.1
1.3
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
16
87
1.87
1.47
2.3
2.8
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
7
28
2.52
1.45
1.4
1.9
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
7
28
2.52
1.45
1.0
1.3
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
7
28
2.52
1.45
1.0
1.3
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
356
3352
1.30
1.45
5.6
4.6
mu/l
2.0
2.3
0.52
329
3012
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
36
247
1.50
1.43
1.9
1.6
—
—
—
0
0
(1002224) Polysomnography panel
6
136
0.43
1.42
1.2
1.1
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
13
67
1.97
1.39
2.9
3.3
u/ml
15.8
26.2
0.50
13
67
(3025018) Bordetella pertussis Ab [Titer] in Serum
5
17
2.96
1.36
1.0
1.2
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
95
775
1.29
1.34
3.9
4.1
ng/l
82.7
239.1
1.55
80
639
(4010399)
19
305
0.61
1.33
1.5
1.4
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
0
40
0.00
1.33
0.0
2.7
—
654.3
—
0
24
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
48
356
1.39
1.29
1.5
1.5
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
216
1940
1.22
1.29
2.5
2.6
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
10
48
2.11
1.28
1.9
1.6
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
45
332
1.39
1.25
1.5
1.5
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
299
2779
1.23
1.25
3.8
4.2
mm/h
17.6
13.1
3.40
280
2542
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
8
36
2.24
1.25
1.5
1.2
—
—
—
0
0
(3004451) EKG impression Narrative
6
25
2.42
1.24
1.0
1.4
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
11
56
1.99
1.23
1.1
1.0
—
—
—
0
0
(3019225) pH of Specimen
50
377
1.37
1.22
7.0
4.4
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
370
3523
1.28
1.22
7.6
6.3
mmol/mol
40.8
40.5
0.28
358
3258
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
5
19
2.65
1.22
1.6
2.1
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
5
19
2.65
1.22
1.4
2.0
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
8
38
2.12
1.19
1.5
1.3
pmol/l
282.3
287.2
—
8
30
(3017817) Protein [Mass] in Urine collected for unspecified duration
8
38
2.12
1.19
3.4
3.1
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
14
79
1.80
1.18
1.2
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
14
79
1.80
1.18
1.2
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
10
50
2.02
1.17
1.9
1.6
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
10
50
2.02
1.17
1.9
1.6
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
10
50
2.02
1.17
1.9
1.6
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
15
87
1.75
1.16
1.2
1.2
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
5
20
2.52
1.15
2.4
2.0
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
5
20
2.52
1.15
1.4
1.9
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
12
65
1.87
1.14
1.1
1.4
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
14
80
1.77
1.14
2.5
2.5
%
14.1
16.3
—
8
39
(3001019) Free T4 and TSH panel - Serum or Plasma
17
104
1.66
1.11
1.5
1.9
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
20
128
1.59
1.10
3.5
6.9
mmol/l
1.5
1.2
0.60
13
112
(3035320) C reactive protein [Mass/volume] in Body fluid
5
21
2.40
1.09
2.0
2.0
—
—
—
0
0
(4062490)
7
32
2.21
1.08
1.1
1.3
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
44
573
0.74
1.08
1.3
1.3
u/ml
1.2
14.4
3.69
17
212
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
34
246
1.41
1.07
2.5
3.7
mmol/l
0.7
1.9
0.77
24
186
(3013512) EKG study
138
1206
1.21
1.05
4.0
4.1
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
13
75
1.76
1.04
2.2
2.5
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
44
336
1.34
1.02
3.2
3.4
g/l
64.7
66.7
0.93
39
306
(3004716) Salmonella sp identified in Stool by Organism specific culture
24
164
1.49
1.01
1.2
1.3
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
0
29
0.00
0.98
0.0
1.2
—
81.8
—
0
6
(3016750) Collection duration of Urine
0
30
0.00
0.97
0.0
2.8
—
502.8
—
0
20
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
10
54
1.87
0.97
1.5
1.3
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
9
50
1.82
0.97
2.0
1.6
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
115
996
1.21
0.96
4.1
3.5
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
0
32
0.00
0.95
0.0
1.0
—
32.8
—
0
18
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
0
32
0.00
0.95
0.0
1.0
—
600.6
—
0
19
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
0
32
0.00
0.95
0.0
1.0
—
243.9
—
0
19
(3005988) Vibrio sp identified in Specimen by Organism specific culture
9
51
1.78
0.95
2.0
1.5
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
118
1028
1.20
0.93
4.1
4.2
estimate
0.0
0.0
0.00
48
328
(3011397) Hemoglobin [Presence] in Urine by Test strip
101
869
1.21
0.90
3.3
3.9
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
48
381
1.29
0.87
2.6
1.7
%
1.6
1.6
0.16
39
327
(3028026) IgM [Mass/volume] in Serum or Plasma
32
240
1.36
0.85
1.9
1.8
g/l
1.1
1.4
0.66
27
215
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
6
33
1.83
0.79
1.2
1.0
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
18
256
0.69
0.78
1.8
1.8
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
0
27
0.00
0.77
0.0
1.2
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
38
298
1.30
0.77
3.3
2.6
g/l
10.0
10.6
0.42
33
271
(3009343) pH of Capillary blood
34
264
1.31
0.74
2.8
3.6
ph
7.4
7.4
—
7
29
(40768795) Lymph node Pathology biopsy report
7
38
1.86
0.74
1.0
1.1
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
79
679
1.20
0.73
1.6
1.5
g/l
2.5
2.6
0.27
51
399
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
25
2.01
0.73
1.4
1.8
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
5
25
2.01
0.73
1.6
4.2
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
7
40
1.76
0.71
1.1
1.4
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
9
57
1.59
0.71
1.3
1.7
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
36
284
1.29
0.70
4.3
4.5
%
0.5
1.1
0.21
11
86
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
158
1442
1.15
0.69
4.3
4.1
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
11
69
1.61
0.69
4.6
1.9
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
9
59
1.54
0.68
1.0
1.1
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
5
27
1.86
0.68
1.6
4.1
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
5
27
1.86
0.68
1.2
2.0
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
14
94
1.51
0.67
1.6
1.4
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
7
44
1.60
0.65
4.7
2.2
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
73
840
0.84
0.65
4.0
4.3
kg/l
1.0
1.0
0.31
16
114
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
86
755
1.17
0.63
1.3
1.2
u/ml
0.8
1.4
1.22
23
201
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
43
517
0.81
0.61
4.2
4.8
%
34.1
32.1
0.45
31
342
(3022806) Fractional oxyhemoglobin in Capillary blood
8
52
1.55
0.59
2.3
2.0
%
91.4
90.5
—
8
52
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
7
114
0.61
0.58
1.7
2.1
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
0
23
0.00
0.58
0.0
1.2
—
0.1
—
0
14
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
14
194
0.71
0.56
1.3
1.3
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
9
60
1.51
0.54
1.2
1.2
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
6
38
1.59
0.54
1.2
1.1
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
6
39
1.55
0.53
1.3
1.2
u/l
52.3
52.3
—
6
24
(3019832) Treponema pallidum Ab [Presence] in Serum
9
134
0.66
0.52
1.8
1.4
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
37
307
1.22
0.51
4.4
4.4
%
0.2
0.1
0.06
12
103
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
16
118
1.37
0.51
1.6
1.6
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
136
1255
1.12
0.50
2.8
3.0
mmol/l
6.8
7.5
1.41
113
1025
(3002179) Metamyelocytes/100 leukocytes in Blood
35
291
1.22
0.48
4.6
4.2
%
1.0
0.3
0.75
11
81
(3026493) Urate [Moles/volume] in Serum or Plasma
112
1024
1.12
0.48
3.1
2.8
umol/l
378.3
8380.7
5.00
96
867
(40768793) Breast Pathology biopsy report
12
86
1.41
0.45
1.3
1.3
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
20
157
1.29
0.44
3.4
2.3
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
89
807
1.13
0.44
1.7
1.7
mg/l
1.5
1.3
0.44
71
643
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
5
31
1.62
0.43
1.4
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
5
31
1.62
0.43
1.4
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
5
31
1.62
0.43
1.4
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
5
31
1.62
0.43
1.4
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
5
31
1.62
0.43
1.4
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
5
31
1.62
0.43
1.4
1.2
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
6
91
0.65
0.42
1.2
1.2
—
2.5
—
0
15
(3049717) Cytology report of Urine Cyto stain
14
183
0.76
0.41
5.7
2.6
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
0
15
0.00
0.41
0.0
1.1
—
2.3
—
0
15
(3015183) Erythrocyte sedimentation rate
0
16
0.00
0.41
0.0
1.4
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
0
17
0.00
0.40
0.0
1.6
—
67.5
—
0
11
(3037556) Urate [Mass/volume] in Serum or Plasma
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
8
60
1.34
0.40
1.1
1.1
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
86
783
1.12
0.40
4.9
4.9
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
17
133
1.29
0.39
1.6
1.6
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
19
0.00
0.39
0.0
1.0
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
131
1223
1.10
0.39
2.7
3.2
mg/l
77.7
301.7
1.24
89
786
(3000093) Morphology [Interpretation] in Blood Narrative
5
37
1.36
0.37
1.0
1.2
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
25
208
1.21
0.36
1.3
1.2
iu/ml
143.8
143.2
—
5
76
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
5
80
0.62
0.35
1.0
1.2
—
—
—
0
0
(4146454)
6
43
1.40
0.35
2.2
2.7
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
37
321
1.17
0.35
3.1
2.8
ml/min/173m2
57.8
61.2
0.21
17
140
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
13
100
1.31
0.34
4.3
1.7
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
20
242
0.82
0.33
2.8
2.6
e9/l
3.5
4.1
0.76
14
184
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
6
88
0.68
0.33
1.0
1.2
mg/l
466.3
485.4
—
6
82
(4306422)
6
46
1.31
0.33
1.5
1.3
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
6
90
0.66
0.33
1.2
1.2
—
3.1
—
0
14
(3000330) Specific gravity of Urine by Test strip
25
212
1.19
0.31
4.6
3.9
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
10
76
1.32
0.28
1.4
1.5
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
42
468
0.89
0.28
1.4
1.3
titre
537.1
472.1
—
7
111
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
9
116
0.77
0.27
2.8
2.0
mg/l
10.9
13.6
—
9
108
(4034850)
9
119
0.75
0.27
8.3
10.5
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
19
159
1.20
0.27
1.1
1.0
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
13
104
1.26
0.26
4.0
1.7
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
13
160
0.81
0.26
1.1
1.1
—
6.2
—
0
5
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
5
75
0.66
0.26
1.2
1.2
—
13.6
—
0
6
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
5
75
0.66
0.26
1.2
1.8
pmol/l
195.8
241.0
—
5
68
(3017181) Myelocytes/100 leukocytes in Blood
37
330
1.13
0.26
4.4
4.2
%
1.0
1.0
0.03
12
115
(44816559) Phosphatidylethanol [Mass/volume] in Blood
9
74
1.22
0.25
1.3
1.2
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
17
142
1.20
0.25
4.5
3.2
g/l
0.5
0.2
0.53
12
51
(46235355) HIV 1 and 2 tests - Meaningful Use set
45
408
1.11
0.24
1.7
1.6
—
—
—
0
0
(4094501)
12
97
1.24
0.23
1.0
1.1
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
161
1548
1.06
0.23
4.6
5.2
ug/l
2.3
2.7
0.56
141
1379
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
11
88
1.26
0.22
1.1
1.1
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
10
0.00
0.21
0.0
8.4
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
10
0.00
0.21
0.0
2.0
—
—
—
0
0
(3008898) HLA-B27 [Presence]
8
101
0.79
0.21
1.0
1.1
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
8
104
0.77
0.21
1.5
1.4
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(4015189)
0
12
0.00
0.21
0.0
2.7
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
95
902
1.07
0.20
3.0
3.1
ug/l
0.8
0.8
0.03
68
622
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
6
51
1.18
0.19
1.5
1.7
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
6
51
1.18
0.19
1.3
1.1
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
371
3665
1.07
0.19
5.9
4.9
mmol/l
6.3
6.0
2.88
359
3318
(3045142) Bone marrow Pathology biopsy report
6
52
1.16
0.19
1.0
1.2
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
23
204
1.13
0.18
2.6
2.4
%
0.7
0.7
0.02
23
198
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
7
60
1.17
0.18
1.4
1.8
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
13
152
0.85
0.17
4.8
1.9
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
19
215
0.88
0.17
1.3
1.4
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
8
69
1.16
0.16
1.4
1.7
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
8
70
1.15
0.16
2.5
2.8
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
8
73
1.10
0.16
1.3
1.5
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
6
79
0.76
0.15
1.3
1.7
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
47
502
0.93
0.15
12.2
7.7
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
25
226
1.11
0.15
4.8
2.8
e6/l
0.2
0.3
0.42
25
221
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
7
86
0.81
0.14
3.4
1.7
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
14
160
0.87
0.14
1.4
1.5
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
58
612
0.94
0.14
1.1
1.3
iu/ml
25.3
39.4
0.56
23
195
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
16
180
0.88
0.13
1.6
1.6
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
14
159
0.88
0.13
1.4
2.1
—
—
—
0
0
(3022313) Gas panel - Capillary blood
18
200
0.90
0.12
3.5
3.6
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
27
249
1.09
0.12
1.3
1.2
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
31
288
1.08
0.12
3.5
2.7
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
13
114
1.14
0.12
1.4
1.3
—
—
—
0
0
(3000492) Spirometry study
31
332
0.93
0.11
1.3
1.5
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
12
106
1.14
0.10
1.2
1.1
—
—
—
0
0
(21494434) Karyotype in Bone marrow
5
47
1.06
0.09
1.6
1.2
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
5
48
1.04
0.09
1.2
1.1
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
5
48
1.04
0.09
1.4
1.3
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
5
62
0.80
0.08
1.0
1.3
—
270.4
—
0
25
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
5
63
0.79
0.08
1.0
1.7
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
5
64
0.78
0.08
4.4
4.0
%
3.2
1.7
—
5
54
(3048929) Epstein Barr virus Ab [Presence] in Serum
10
88
1.14
0.08
1.2
1.2
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
6
70
0.86
0.07
1.2
1.2
—
40.5
—
0
7
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
6
72
0.83
0.07
1.2
1.1
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
6
75
0.80
0.07
1.0
1.1
mmol/l
3.7
3.8
—
6
68
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
8
76
1.05
0.07
1.1
1.5
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
8
78
1.03
0.07
1.4
1.6
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
15
138
1.09
0.06
8.0
4.7
—
2.2
—
0
16
(3020682) Albumin/Creatinine [Ratio] in Urine
132
1299
1.02
0.06
3.5
3.9
mg/mmol
22.3
7.5
0.93
84
818
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
13
141
0.92
0.05
1.9
1.7
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
46
474
0.97
0.05
1.3
1.4
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
41
398
1.03
0.04
1.3
1.4
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
11
119
0.92
0.04
1.6
1.3
g/l
0.3
0.2
0.48
11
114
(3000494) Fungus identified in Specimen by Culture
51
498
1.03
0.03
1.5
1.4
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
14
132
1.06
0.02
1.1
1.0
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
11
103
1.07
0.02
5.9
5.4
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
14
147
0.95
0.01
2.1
2.1
ug/l
159.9
313.2
1.06
14
137
(21494755) Public health laboratory ask at order entry panel
24
233
1.03
0.01
1.2
1.4
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
121
1204
1.01
0.00
3.0
2.1
u/l
193.4
218.1
0.24
114
1128
(3037756) Immunofixation for Serum or Plasma
10
102
0.98
0.00
2.0
1.7
—
—
—
0
0
(3022621) pH of Urine by Test strip
26
263
0.99
0.00
4.6
3.0
—
—
—
0
0
(40761535) Cells panel - Urine sediment
35
347
1.01
0.00
2.9
3.5
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
37
367
1.01
0.00
1.7
1.6
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
12
121
0.99
0.00
8.3
4.7
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
15
149
1.01
0.00
3.4
3.0
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
125
1249
1.00
0.00
4.1
4.6
%
21.6
21.3
0.09
61
635
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
5
51
0.98
0.00
3.0
3.9
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
9
0.00
0.00
0.0
8.2
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
5
51
0.98
0.00
1.0
1.1
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
11.5
—
0
5
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
1.8
—
0
5
(3042733) HLA Ab [Presence] in Serum
0
6
0.00
0.00
0.0
3.8
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
6
59
1.02
0.00
1.0
1.5
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.4
—
41.6
—
0
8
(3005011) Chlamydia sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
9
90
1.00
0.00
1.4
2.4
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
6
64
0.94
0.00
1.0
1.2
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
63
0.95
0.00
1.5
1.7
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
6
67
0.89
0.00
1.3
1.4
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
7
74
0.95
0.00
1.3
2.6
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.2
—
21.9
—
0
5
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
8
86
0.93
0.00
1.6
1.5
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(44806071)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
8
0.00
0.00
0.0
9.0
—
—
—
0
0
(3016330) Potassium [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
8
0.00
0.00
0.0
4.9
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_SMALL_INTESTINE_NEUROENDOCRINE – Neuroendocrine tumor and carcinoma of small intestine
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).